# The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil

> **NCT02530697** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Brasilia** · enrollment: 160 (estimated)

## Conditions studied

- Leishmaniasis

## Interventions

- **DRUG:** Meglumine antimoniate
- **DRUG:** Miltefosine
- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT02530697
- **Lead sponsor:** University of Brasilia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-08
- **Primary completion:** 2025-08
- **Final completion:** 2026-08
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530697, "The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02530697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*